ArticleFrontiers in immunology2026

Genomic alterations and dynamic molecular residual disease monitoring predict pathological response to neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Dijian Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.